Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22129579 | 1.00 | ALDH1A1 (0.36) | ALDH1A1THRBMEN1KMT2ATSHR | |
| SCHEMBL9307017 | 0.96 | ALDH1A1 (0.33) | ALDH1A1KMT2A | |
| SCHEMBL18239998 | 0.96 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL3957944 | 0.96 | ALDH1A1 (0.33) | ALDH1A1KMT2A | |
| SCHEMBL1461345 | 0.96 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL28452 | 0.95 | — | — | |
| SCHEMBL552393 | 0.95 | ALDH1A1 (0.39) | ALDH1A1THRBMEN1KMT2ATSHR | |
| SCHEMBL3227368 | 0.92 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL6890483 | 0.91 | — | — | |
| SCHEMBL623971 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 320 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116715584-A | Tetrahydronaphthalene bicyclo [4.3.1] decane compound and preparation method thereof | 五邑大学 | 2023-09-08 | — | — | CN | claimed |
| EP-2773430-B1 | PERFUMING COMPOSITIONS AND USES THEREOF | FIRMENICH & CIE (CH) | 2019-10-09 | — | — | EP | claimed |
| US-10336966-B2 | Fragrance compositions and uses thereof | THE PROCTER & GAMBLE COMPANY (US) | 2019-07-02 | — | — | US | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| US-9814661-B2 | Fragrance compositions | THE PROCTER & GAMBLE COMPANY (US) | 2017-11-14 | — | — | US | claimed |
| EP-2961374-B1 | FRAGRANCE COMPOSITIONS | PROCTER & GAMBLE (US) | 2017-01-25 | — | — | EP | claimed |
| US-9428712-B2 | Perfuming compositions and uses thereof | FIRMENICH SA (CH) | 2016-08-30 | — | — | US | claimed |
| EP-2961374-A1 | FRAGRANCE COMPOSITIONS | The Procter & Gamble Company (US) | 2016-01-06 | — | — | EP | claimed |
| US-20150164764-A1 | Fragrance Compositions | THE PROCTER & GAMBLE COMPANY | 2015-06-18 | — | — | US | claimed |
| WO-2015089246-A1 | FRAGRANCE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2015-06-18 | — | — | WO | claimed |
| EP-1657239-B1 | Chromene compound | TOKUYAMA CORP (JP) | 2010-08-11 | — | — | EP | claimed |
| CN-122094943-A | Novel 1,2, 4-oxadiazoles as fungicides | — | 2026-05-26 | — | — | CN | disclosed |
| WO-2026103730-A1 | DIAZAHETEROCYCLIC DERIVATIVE OF PYRIDOARYL GROUP HAVING KAPPA RECEPTOR ANTAGONISTIC ACTIVITY AND COMPOSITION THEREOF, AND USE | 江苏恩华药业股份有限公司 | 2026-05-21 | — | — | WO | disclosed |
| WO-2026090589-A1 | HETEROCYCLIC HBS1L DEGRADERS | TANGO THERAPEUTICS, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| US-20260078117-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS INC (US) | 2026-03-19 | — | — | US | disclosed |
| US-20030096117-A1 | Chromene compound | TOKUYAMA CORPORATION (JP) | 2003-05-22 | — | — | US | disclosed |
| EP-1184379-A1 | CHROMENE COMPOUND | TOKUYAMA CORPORATION (JP) | 2002-03-06 | — | — | EP | disclosed |
| US-6133258-A | PYRIDOTHIAZINE DERIVATIVE; FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, MULTIPLE SCLEROSIS, PAIN, GLAUCOMA | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 2000-10-17 | — | — | US | disclosed |
| CN-1202109-A | Kainic acid neuronotoxicity inhibitors and pyridothioazine derivatives | YAMANOUCHI PHARMA CO LTD (JP) | 1998-12-16 | — | — | CN | disclosed |
| EP-0878196-A1 | KAINIC ACID NEURONOTOXICITY INHIBITORS AND PYRIDOTHIAZINE DERIVATIVES | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1998-11-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150164764-A1 | Fragrance Compositions | OGG1, ALKBH5, MYB | ALDH1A1 1367/4885THRB 4320/4885MEN1 3707/4885 |
| US-10336966-B2 | Fragrance compositions and uses thereof | CUTA, DPM1, PLIN5 | ALDH1A1 1263/4885THRB 4417/4885MEN1 3199/4885 |
| US-20260078117-A1 | COMPOUNDS AND METHODS OF USE | NR3C2, ADRA1A, CNR1 | ALDH1A1 100/4885THRB 995/4885MEN1 1978/4885 |
| US-20030096117-A1 | Chromene compound | SMARCE1, SMARCD2, SMARCB1 | ALDH1A1 3101/4885THRB 4732/4885MEN1 2413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.